Thubilux Pharma SpA has received a structured loan of US$2.7 million from a leading Italian bank
Tubilux Pharma SpA has successfully raised funds through a structured loan from Cassa Depositi e Prestiti SpA and Banca Intesa San Paolo SpA to support an investment plan for a new production facility which has all the FDA requirements to enter the USA market.
Tubilux Pharma is a leading, privately-held ophthalmic and pharmaceuticals company that develops and markets a range of proprietary, over-the-counter, and branded generic products, with distribution in approximately 30 countries. The firm's customers are large multinational pharmaceutical companies that outsource their production of ophthalmic products to specialized manufactures through medium-term supply contracts (3-5 years).
Oaklins' team in Italy advised Thubilux Pharma SpA in the structuring, negotiation and closing of a long-term debt financing from a leading Italian bank, backed by Cassa Depositi e Prestiti.
Talk to the deal team
Related deals
MEDIK Hospital Design Group has been acquired by STERIS
The private shareholders of MEDIK Hospital Design Group have sold their shares to STERIS plc. Together, MEDIK and STERIS will expand their offerings for hospitals and ambulatory surgery centers worldwide. MEDIK’s solutions ideally complement STERIS’ existing portfolio, enabling the combined group to strengthen its position as a leading provider of turnkey room solutions in surgical and IPT environments. The MEDIK management team will actively support the next phase of growth.
Learn moreAgrova International has acquired Sunrise Eggs
Agrova International, led by its founder Jurijs Adamovičs, has acquired 100 percent of the shares in Sunrise Eggs, a UK-based egg production and distribution company. This acquisition significantly expands Agrova’s operational footprint and strengthens its position as a pan-European player in the egg and egg protein industry. The transaction was supported with funding from Accession Capital Partners (ACP), a growth capital provider with experience in the agriculture sector.
Learn moreSmile Invest has secured debt financing for the acquisition of RB+ Groep
Smile Invest has successfully acquired a majority stake in RB+ Groep, a specialist in comprehensive fire prevention solutions operating under the brands Van der Aa, Firejob and Preficon Europe, with a strong focus on constructional fire prevention. This transaction supports RB+’s growth ambitions and enables the company to expand into adjacent and international markets.
Learn more